Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents
Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Natalia Calonghi(University of Bologna), Joseph Durante(University of Urbino), Gabriele Micheletti(University of Bologna), Paolo Caruana(University of Bologna), Giovanni Martinelli(University of Bologna), Fabio Mantellini(University of Urbino), Dario Telese(University of Bologna), Carla Boga(University of Bologna), Samantha Bruno(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa)
Cited by 19
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644